Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
May 15, 2013 (Vol. 33, No. 10)

Pathways to Science

  • Includes material for all education/career stages
  • None

The pathways to careers in science are long and arduous, but they can be even more difficult to traverse for underrepresented minorities. The Pathways to Science project out of the Institute for Broadening Participation (IBP) is an excellent online resource aimed at increasing and supporting diversity in the STEM fields (science, technology, engineering, and mathematics). The website contains valuable information for students/scientists at any stage of their careers, from K–12 to faculty members. So what are some of the tools available on the site? For K–12 students there are listings of high school programs in STEM and tips for applying and financing college. College students can browse more than 650 paid summer research positions and internships for undergraduates and can read about applying to graduate school. At the graduate student and postdoc level, there is an emphasis on applying for fellowships and choosing an appropriate postdoctoral laboratory. Finally, the faculty section includes information on conferences and mentoring underrepresented students.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »